Work

Duration of androgen deprivation therapy for high-risk prostate cancer: Application of randomized trial data in a tertiary referral cancer center.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.2_suppl.33

Authors: Vinayak Muralidhar, Meredith M. Regan, Lillian Werner, Mari Nakabayashi, Carolyn Evan, Joaquim Bellmunt, Toni K. Choueiri, Aymen Elfiky, Lauren Christine Harshman, Rana R. McKay, Mark Pomerantz, Christopher Sweeney, Mary-Ellen Taplin, Philip W. Kantoff, Paul L. Nguyen

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard University, Stanford Medicine, Stanford University, Dana-Farber Brigham Cancer Center

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4231832937

Cites:

Cited by: 1

Related to: 10